Warnken, LLC Attorneys at Law, Attorneys & Lawyers, Pikesville, MD
Array Array Array


Criminal and Civil Litigation

Trial and Appellate

Workers' Compensation

Helping Injured Workers

One Case at a Time

Law Enforcement

General Counsel to the Maryland Troopers’ Association

Experience against more than 35 different agencies


Counsel on more than 250 appeals in State and Federal Courts

Multiple cases in the Supreme Court of the United States

Helpful Links

Warnken, LLC Attorneys At Law

Warnken, LLC started more than 20 years ago.  The senior member of the firm, Byron L. Warnken, Esq., has been an attorney for more than 35 years.  He is also a full-time law professor at the University of Baltimore School of Law.  Warnken teaches various criminal law related classes.  In the past, he taught issues in law enforcement.  From his classes, came his practice.  In the beginning, being a scholar meant interesting specialty litigation at the appellate level.  Things grew from there.


Warnken, LLC has handled more than 1300 criminal cases in more than 20 years of practice.   This includes all phases of criminal litigation, including trial work and post-verdict work.  Post-verdict means criminal appeals, post conviction, sentencing and other collateral review.  Professor Byron L. Warnken teaches criminal law and constitutional criminal procedure.  He is also the author of Maryland Criminal Procedure, a 1940-page three-volume treatise on the subject.

Warnken, LLC’s civil litigation practice, at this point, is primarily appeals.  However, through of-counsel relationships, we handle car accidents, negligence, contested liability cases, personal injury, medical malpractice, and other injuries or disputes.

Workers’ Compensation

Workers’ compensation is by far the fastest growing practice area at Warnken, LLC.  Our comp practice is likely the fastest growing in the state.  Warnken, LLC had less than 20 comp files at any given time two and a half years ago.  Today there are approximately 100.

Our comp practice grew from serving law enforcement.  Being one of the most dangerous jobs, police officers and other public safety employees often need counsel for workplace injuries.  In order to serve our existing clients, we gained the expertise.

Law Enforcement

For more than 15 years, Warnken, LLC has been general counsel to the Maryland Troopers Association.  We handle administrative discipline, trial boards, disability retirement, grievances, and generally anything else active or retired law enforcement personnel face.  We take great pride in the work.

The Latest

Pain Killer Lawsuits – An Update

On July 31st, we wrote a letter to Peter Angelos and Steve Silverman urging lawsuits be filed against painkiller manufacturers. Currently, there are lawsuits against Purdue Pharma and others filed in Orange and Santa Clara Counties in California and another by the city of Chicago. Purdue has won dismissals in more than 400 personal-injury lawsuits and 10 would-be class actions. Now, a potentially landmark lawsuit has surfaced in Kentucky against Purdue.


The Case

The lawsuit is entitled Commonwealth of Kentucky v. Purdue Pharma LP, 07-CI-01393, Pike Circuit Court (Kentucky).

The state of Kentucky filed a civil suit against Purdue, alleging that the company trained its sales team to falsely portray OxyContin as much safer than it really is. The pill’s long-acting feature makes it more potent than older painkillers. Addicts began crushing the tablets to extract the active ingredients as a way around the time-release function. The addicts can then snort or inject the drug for an immediate and intense high.

Kentucky’s 12 claims against the company include Medicaid fraud, false advertising, creating a public nuisance, and unjust enrichment. Abbott Laboratories, which at one time co-promoted OxyContin with Purdue, is also named as a defendant.

Depending on Circuit Judge Steven Combs’ decision, Purdue could not only face a $1 billion penalty, but also similar litigation across the country.


Deceptive Marketing

Arthur Sackler, co founder of Purdue, was a pioneer of pharmaceutical marketing. He created the first medical-journal advertising insert to promote a drug and pushed for hiring sales reps to go to doctors’ offices, according to a Bloomberg’s article.

To saturate the market with OxyCotin, Purdue “polluted virtually every resource for information on the use of opioids,” the Chicago lawsuit claims. Indeed, all three lawsuits claim that Purdue helped create OxyContin addiction through aggressive and deceptive market. They allegedly paid doctors (known as “key opinion leaders”) to support and endorse the drugs, funded front organizations to promote the drug, and manipulated scientific consensus in favor of pain pill use.


Effect in Pike County

Purdue has unsuccessfully attempted to get the case moved out of Pike County for 6 years, claiming that it can’t get a fair trial because of the widespread OxyContin use in the area. Lawyers for Purdue even hired a consultant to survey Pike County residents to try to determine whether the county could seat an impartial jury. The results were filed in the Kentucky court: Almost 40% said they knew someone who got into criminal trouble because of an OxyContin addiction. One-third said they knew someone who overdosed or was seriously hurt taking the drug, and 29% said they knew someone who died. Nine out of 10 polled residents reported that OxyContin had a “devastating effect” on the community.

In essence, the company claims their product has had such a devastating impact on the community, it’s near impossible to find a jury pool who hasn’t been touched in a negative manner by their product.

Since top executives paid $634 million in fines for “misbranding” OxyContin as less addictive than other opioids in 2007, Purdue has denied all claims against them. The company released a statement saying, “Since [2001] we’ve dedicated ourselves to combating prescription drug abuse, most significantly by formulating OxyContin and other pain medications with abuse-deterrent properties.”

Sources for this post include Bloomberg News and Businessweek.

Continue Reading »